Polish portfolio

Polpharma is the largest Polish manufacturer of pharmaceuticals and a leader in the Central and Eastern European market. The company specializes in a wide range of generic drugs, over-the-counter (OTC) products, and active pharmaceutical ingredients (APIs), while its subsidiary, Polpharma Biologics, focuses on the development and manufacturing of biosimilars. Polpharma operates several manufacturing plants and R&D centers across Poland, Russia, and Kazakhstan, providing affordable healthcare solutions across multiple therapeutic areas including cardiology, gastroenterology, and neurology. Through its biologics arm, the company has established itself as a significant player in the global biosimilar market, with a robust pipeline targeting high-value inflammatory and ophthalmic conditions.